MUC4 modulates human glioblastoma cell proliferation and invasion by upregulating EGFR expression

Neuroscience Letters

Volumn 566, Issue , 2014, Pages 82-87

  Li, Weihua ^a   Wu, Chunming ^a   Yao, Yiqun ^a   Dong, Bin ^a   Wei, Zhenqing ^a   Lv, Xiupeng ^a   Zhang, Jian ^a   Xu, Yinghui ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

EGFR; GBM; Invasion; MUC4; Proliferation

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MUCIN 4; SMALL INTERFERING RNA;

ARTICLE; CANCER PROGNOSIS; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLONOGENESIS; CONTROLLED STUDY; ENZYME INHIBITION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; MODULATION; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

EGFR; GBM; INVASION; MUC4; PROLIFERATION;

BRAIN NEOPLASMS; CELL MOVEMENT; CELL PROLIFERATION; GLIOBLASTOMA; HUMANS; MUCIN-4; NEOPLASM INVASIVENESS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA INTERFERENCE; UP-REGULATION;

EID: 84896080665     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.02.033     Document Type: Article

References (39)

1. Wang Y., Jiang T. Understanding high grade glioma: molecular mechanism, therapy and comprehensive management. Cancer Lett. 2013, 331:139-146.
2. Giese A., Bjerkvig R., Berens M.E., Westphal M. Cost of migration: invasion of malignant gliomas and implications for treatment. J. Clin. Oncol. 2003, 21:1624-1636.
3. Parsons D.W. The evolving picture of the glioblastoma genome. Oncotarget 2010, 1:237-238.
4. Bartek J., Ng K., Bartek J., Fischer W., Carter B., Chen C.C. Key concepts in glioblastoma therapy. J. Neurol. Neurosurg. Psychiatry 2012, 83:753-760.
5. Chakraborty S., Jain M., Sasson A.R., Batra S.K. MUC4 as a diagnostic marker in cancer. Expert Opin. Med. Diagn. 2008, 2:891-910.
6. Tsutsumida H., Goto M., Kitajima S., Kubota I., Hirotsu Y., Wakimoto J., Batra S.K., Imai K., Yonezawa S. MUC4 expression correlates with poor prognosis in small-sized lung adenocarcinoma. Lung Cancer 2007, 55:195-203.
7. Singh A.P., Chaturvedi P., Batra S.K. Emerging roles of MUC4 in cancer: a novel target for diagnosis and therapy. Cancer Res. 2007, 67:433-436.
8. Ponnusamy M.P., Singh A.P., Jain M., Chakraborty S., Moniaux N., Batra S.K. MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells. Br. J. Cancer 2008, 99:520-526.
9. Choudhury A., Moniaux N., Winpenny J.P., Hollingsworth M.A., Aubert J.P., Batra S.K. Human MUC4 mucin cDNA and its variants in pancreatic carcinoma. J. Biochem. 2000, 128:233-243.
10. Jonckheere N., Perrais M., Mariette C., Batra S.K., Aubert J.P., Pigny P., Van Seuningen I. A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-beta in pancreatic carcinogenesis. Oncogene 2004, 23:5729-5738.
11. Carraway K.L., Price-Schiavi S.A., Komatsu M., Jepson S., Perez A., Carraway C.A. Muc4/sialomucin complex in the mammary gland and breast cancer. J. Mammary Gland Biol. Neoplasia 2001, 6:323-337.
12. Mukhopadhyay P., Lakshmanan I., Ponnusamy M.P., Chakraborty S., Jain M., Pai P., Smith L.M., Lele S.M., Batra S.K. MUC4 overexpression augments cell migration and metastasis through EGFR family proteins in triple negative breast cancer cells. PLoS One 2013, 8:e54455.
13. Kitazono I., Higashi M., Kitamoto S., Yokoyama S., Horinouchi M., Osako M., Shimizu T., Tabata M., Batra S.K., Goto M., Yonezawa S. Expression of MUC4 mucin is observed mainly in the intestinal type of intraductal papillary mucinous neoplasm of the pancreas. Pancreas. 2013, 42(7):1120-1128.
14. Ponnusamy M.P., Seshacharyulu P., Vaz A., Dey P., Batra S.K. MUC4 stabilizes HER2 expression and maintains the cancer stem cell population in ovarian cancer cells. J. Ovarian Res. 2011, 4:7.
15. Workman H.C., Miller J.K., Ingalla E.Q., Kaur R.P., Yamamoto D.I., Beckett L.A., Young L.J., Cardiff R.D., Borowsky A.D., Carraway K.L., Sweeney C., Carraway K.L. The membrane mucin MUC4 is elevated in breast tumor lymph node metastases relative to matched primary tumors and confers aggressive properties to breast cancer cells. Breast Cancer Res. 2009, 11:R70.
16. Carraway K.L., Theodoropoulos G., Kozloski G.A., Carothers Carraway C.A. Muc4/MUC4 functions and regulation in cancer. Future Oncol. 2009, 5:1631-1640.
17. Ponnusamy M.P., Lakshmanan I., Jain M., Das S., Chakraborty S., Dey P., Batra S.K. MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells. Oncogene 2010, 29:5741-5754.
18. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
19. Shien K., Toyooka S., Yamamoto H., Soh J., Jida M., Thu K.L., Hashida S., Maki Y., Ichihara E., Asano H., Tsukuda K., Takigawa N., Kiura K., Gazdar A.F., Lam W.L., Miyoshi S. Acquired resistance to EGFR inhibitors is associated with a manifestation of stem cell-like properties in cancer cells. Cancer Res. 2013, 73:3051-3061.
20. Switzer C.H., Glynn S.A., Cheng R.Y., Ridnour L.A., Green J.E., Ambs S., Wink D.A. S-nitrosylation of EGFR and Src activates an oncogenic signaling network in human basal-like breast cancer. Mol. Cancer Res. 2012, 10:1203-1215.
21. Huang P.H., Xu A.M., White F.M. Oncogenic EGFR signaling networks in glioma. Sci. Signal 2009, 2. re6.
22. Costa B.M., Viana-Pereira M., Fernandes R., Costa S., Linhares P., Vaz R., Pinheiro C., Lima J., Soares P., Silva A., Pardal F., Amorim J., Nabico R., Almeida R., Alegria C., Pires M.M., Pinheiro C., Carvalho E., Oliveira P., Lopes J.M., Reis R.M. Impact of EGFR genetic variants on glioma risk and patient outcome. Cancer Epidemiol. Biomarkers Prev. 2011, 20:2610-2617.
23. Kang C.S., Zhang Z.Y., Jia Z.F., Wang G.X., Qiu M.Z., Zhou H.X., Yu S.Z., Chang J., Jiang H., Pu P.Y. Suppression of EGFR expression by antisense or small interference RNA inhibits U251 glioma cell growth in vitro and in vivo. Cancer Gene Ther. 2006, 13:530-538.
24. Ramis G., Thomas-Moya E., Fernandez de Mattos S., Rodriguez J., Villalonga P. EGFR inhibition in glioma cells modulates Rho signaling to inhibit cell motility and invasion and cooperates with temozolomide to reduce cell growth. PLoS One 2012, 7:e38770.
25. Goodenberger M.L., Jenkins R.B. Genetics of adult glioma. Cancer Genet. 2012, 205:613-621.
26. Joseph J.V., Balasubramaniyan V., Walenkamp A., Kruyt F.A. TGF-beta as a therapeutic target in high grade gliomas - promises and challenges. Biochem. Pharmacol. 2013, 85:478-485.
27. Abe T., Tamiya T., Ono Y., Salker A.H., Akiyama K., Ohmoto T. Accumulation of cell cycle regulatory proteins, p21 and p27, induced after hyperthermia in human glioma cells. Int. J. Hyperthermia 2001, 17:499-507.
28. Wagenknecht B., Hermisson M., Eitel K., Weller M. Proteasome inhibitors induce p53/p21-independent apoptosis in human glioma cells. Cell. Physiol. Biochem. 1999, 9:117-125.
29. Anton K., Baehring J.M., Mayer T. Glioblastoma multiforme: overview of current treatment and future perspectives. Hematol. Oncol. Clin. North Am. 2012, 26:825-853.
30. Rachagani S., Macha M.A., Ponnusamy M.P., Haridas D., Kaur S., Jain M., Batra S.K. MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1. Carcinogenesis 2012, 33:1953-1964.
31. Ramsauer V.P., Carraway C.A., Salas P.J., Carraway K.L. Muc4/sialomucin complex, the intramembrane ErbB2 ligand, translocates ErbB2 to the apical surface in polarized epithelial cells. J. Biol. Chem. 2003, 278:30142-30147.
32. Bruyere E., Jonckheere N., Frenois F., Mariette C., Van Seuningen I. The MUC4 membrane-bound mucin regulates esophageal cancer cell proliferation and migration properties: implication for S100A4 protein. Biochem. Biophys. Res. Commun. 2011, 413:325-329.
33. Chauhan S.C., Singh A.P., Ruiz F., Johansson S.L., Jain M., Smith L.M., Moniaux N., Batra S.K. Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125). Mod. Pathol. 2006, 19:1386-1394.
34. Moniaux N., Chaturvedi P., Varshney G.C., Meza J.L., Rodriguez-Sierra J.F., Aubert J.P., Batra S.K. Human MUC4 mucin induces ultra-structural changes and tumorigenicity in pancreatic cancer cells. Br. J. Cancer 2007, 97:345-357.
35. Johnston J.B., Navaratnam S., Pitz M.W., Maniate J.M., Wiechec E., Baust H., Gingerich J., Skliris G.P., Murphy L.C., Los M. Targeting the EGFR pathway for cancer therapy. Curr. Med. Chem. 2006, 13:3483-3492.
36. van Diest P.J., van der Groep P., van der Wall E. EGFR expression predicts BRCA1 status in patients with breast cancer. Clin. Cancer Res. 2006, 12(670). author reply 671.
37. Spano J.P., Lagorce C., Atlan D., Milano G., Domont J., Benamouzig R., Attar A., Benichou J., Martin A., Morere J.F., Raphael M., Penault-Llorca F., Breau J.L., Fagard R., Khayat D., Wind P. Impact of EGFR expression on colorectal cancer patient prognosis and survival. Ann. Oncol. 2005, 16:102-108.
38. Penault-Llorca F., Bibeau F., Arnould L., Bralet M.P., Rochaix P., Sabourin J.C. EGFR expression in colorectal cancer and role in tumorigenesis. Bull. Cancer 2005, 92:S5-S11.
39. Ma D., Hovey R.L., Zhang Z., Fye S., Huettner P.C., Borecki I.B., Rader J.S. Genetic variations in EGFR and ERBB4 increase susceptibility to cervical cancer. Gynecol. Oncol. 2013.